Japan to test coronavirus drug despite risk of birth defects

The Wall Street Journal reports that Japanese authorities are racing to test a drug developed by Fujifilm Holdings (OTCPK:FUJIF), Avigan (favipiravir), for the potential treatment of coronavirus infection.

Avigan was approved in Japan in 2014 as a backup drug in case a new kind of influenza emerged. It has not been used to treat regular flu because animal studies showed the potential for fetal damage or death if pregnant women took the medicine.

(in zdaj pride tojemoznosamovsloveniji...)

The government's decision to launch the trial is controversial since Fujifilm's CEO is a golfing partner of Prime Minister Shinzo Abe who has also received $28K in political donations from the company.

seekingalpha.com/new...th-defects

kudlow je na mojem twitter feedu pozel salve smeha. kot da teh kljukcev marsikdo sploh ne poslusa vec, s smislu "yes yes, whatever you say boss..."

nafta: razpad simbioze med opec in rusijo zgleda ful vazen, ce prav razumem bo zdaj poceni nafta nova normala. zacahnjen 1. april, ko potece trenutni dogovor. posledice znajo bit precej hude, predvsem ko bo to uzgalo na ameriski shale in posledicno se na dolar. prve analize pravijo, da bojo trpeli tudi rusi, ce bo sla se dol, breakeven imajo baje pri cca 40$.

ta japonska je pa sick. to je samogenocid. darwinovo nagrado zasluzijo.

tricky danes vse skupaj spremljat pa se pozicije bejbisitat, fala k. da je ze skoraj vikend pa bo par dni samo en monitor nabijal.